DENTSPLY SIRONA XRAY · NASDAQ
$8.57 -2.94% (-$0.26)
Summary
39 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It earns 16 USD a year on every 100 USD of invested capital.
What to watch
- The company made a loss over the last 12 months.
- Repaying its net debt would take 12.1 years of operating profit.
- Revenue fell by 2.1% a year over the last 3 years.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.0% a year over 5 years. Over the last 3 years it fell by 2.1% a year. For the next fiscal year analysts expect revenue to fall by 2.9%.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $546.0M.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 16.2 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 3.62%
You receive $0.32 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 12
- Hold 19
- Sell 1
Today's price within the analysts' price targets
The average target of $13 is 52% above today's price. 38% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Technologies And Equipment 59%
- Consumables Segment 41%
By region
- Europe 43%
- UNITED STATES 32%
- Other Foreign 25%
Technologies And Equipment brings in 59% of revenue.
Segments in detail